Variable
| |
Total pop
| | |
Females
| | |
Males
| |
---|
A/A
|
A/G-G/G
|
p-value
|
A/A
|
A/G-G/G
|
p-value
|
A/A
|
A/G-G/G
|
p-value
|
---|
n
|
259
|
211
| |
124
|
107
| |
135
|
104
| |
IHD,n (%)
|
65 (25.1)
|
45 (21.3)
|
0.34
|
23 (18.5)
|
21 (19.6)
|
0.84
|
42 (31.1)
|
24 (23.1)
|
0.17
|
DM, n (%)
|
90 (34.7)
|
63 (29.9)
|
0.26
|
41 (33.1)
|
27 (25.2)
|
0.19
|
49 (36.3)
|
36 (34.6)
|
0.79
|
NYHA III, n (%)
|
57 (22.0)
|
37 (17.5)
|
0.23
|
27 (21.8)
|
19 (17.8)
|
0.45
|
30 (22.2)
|
18 (17.3)
|
0.35
|
AF, n (%)
|
31 (12.0)
|
15 (7.1)
|
0.08
|
12 (9.7)
|
6 (5.6)
|
0.25
|
19 (14.1)
|
9 (8.7)
|
0.20
|
EF < 40%, n (%)
|
19 (7.3)
|
17 (8.1)
|
0.77
|
6 (4.8)
|
3 (2.8)
|
0.43
|
13 (9.6)
|
14 (13.5)
|
0.35
|
Hb < 120 g/L, n (%)
|
25 (9.7)
|
26 (12.3)
|
0.35
|
17 (13.7)
|
16 (15.0)
|
0.79
|
8 (2.2)
|
10 (9.6)
|
0.28
|
- AF atrial fibrillation, DM diabetes mellitus, EF ejection fraction, IHD ischemic heart disease, NYHA New York Heart Association functional class